Connection
Allen Cohn to Dasatinib
This is a "connection" page, showing publications Allen Cohn has written about Dasatinib.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.025 |
|
|
|
-
Strickler JH, McCall S, Nixon AB, Brady JC, Pang H, Rushing C, Cohn A, Starodub A, Arrowood C, Haley S, Meadows KL, Morse MA, Uronis HE, Blobe GC, Hsu SD, Zafar SY, Hurwitz HI. Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer. Invest New Drugs. 2014 Apr; 32(2):330-9.
Score: 0.025